Podcast Episodes

Back to Search
Grownup T1Ds: The Missing Support for Adults Living with Diabetes
Grownup T1Ds: The Missing Support for Adults Living with Diabetes

Episode 780

There's a reason we don't call it juvenile diabetes anymore. We all know you grow up and T1D doesn't go anywhere, and that you can be diagnosed at an…

5 months ago

Short Long
View Episode
In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more
In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more

Episode 779

It's In the News, a look at the top headlines and stories in the diabetes community.

This week's top stories: Metformin may help stem macular degener…

5 months, 1 week ago

Short Long
View Episode
Are We Finally Taking Mental Health Seriously in Diabetes Care?
Are We Finally Taking Mental Health Seriously in Diabetes Care?

Episode 778

We all know how important mental health is but unless you are VERY lucky, you're on your own. 

There are the rare programs out there for pediatric en…

5 months, 2 weeks ago

Short Long
View Episode
BONUS Episode: Dexcom Updates From ATTD with  Jessica Castle, VP of Medical Affairs
BONUS Episode: Dexcom Updates From ATTD with Jessica Castle, VP of Medical Affairs

Episode 777

Bonus episode! I had the opportunity to talk to the folks at Dexcom about their presentations at ATTD and I wanted to bring you the interview sooner …

5 months, 3 weeks ago

Short Long
View Episode
In the News… $3 Semaglutide?, New Stem Cell Partnership, "Lyla's Law" Debate, Patient-Led Insulin Dosing in Pregnancy, FDA GLP-1 Crackdown, and more!
In the News… $3 Semaglutide?, New Stem Cell Partnership, "Lyla's Law" Debate, Patient-Led Insulin Dosing in Pregnancy, FDA GLP-1 Crackdown, and more!

Episode 776

It's In the News, a look at the top headlines and stories in the diabetes community.

This week's top stories: Stem Cell Islet Therapy Partnership, "L…

5 months, 3 weeks ago

Short Long
View Episode
Fixing the Most Overlooked Problem in Diabetes: Your Skin
Fixing the Most Overlooked Problem in Diabetes: Your Skin

Episode 775

Why don't we talk about our skin more?!

When you or your child is diagnosed with diabetes, you quickly realize the skin is in for a rough time. Endle…

6 months ago

Short Long
View Episode
In the News... Islet cell transplants update, implantable insulin pump moves forward, Olympics monitored GLP-1s and more!
In the News... Islet cell transplants update, implantable insulin pump moves forward, Olympics monitored GLP-1s and more!

Episode 774

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet tr…

6 months, 1 week ago

Short Long
View Episode
"It's incredibly exciting" - What's next  for Tidepool with CEO Brandon Arbiter
"It's incredibly exciting" - What's next for Tidepool with CEO Brandon Arbiter

Episode 773

Tidepool was founded in 2013, part of the incredible era of DIY diabetes progress, and has since helped change how hundreds of thousands of people wi…

6 months, 2 weeks ago

Short Long
View Episode
In the News... Trump RX, T1D at the Olympics & Superbowl, Ozempic pill launches soon, and more!
In the News... Trump RX, T1D at the Olympics & Superbowl, Ozempic pill launches soon, and more!

Episode 772

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump…

6 months, 3 weeks ago

Short Long
View Episode
The FDA pulled it, but the diabetes community wouldn't let it go. How the T1D1 app made a comeback
The FDA pulled it, but the diabetes community wouldn't let it go. How the T1D1 app made a comeback

Episode 771

Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but on…

7 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us